Minims Pilocarpinenitraat Bausch + Lomb Ireland Limited (Pilocarpine Nitrate)

Pilocarpine nitrate is a direct muscarinic agonist that stimulates M3 receptors in the ciliary muscle. This contraction opens the trabecular meshwork, increasing the drainage of aqueous humor from the anterior chamber, which consequently reduces intra‑ocular pressure.

The dosing regimen for Minims Pilocarpinenitraat is determined by the prescribing clinician based on the patient’s condition, response, and tolerance. The prescriber will specify the number of drops, frequency, and duration appropriate for each individual case.

Safety data for pilocarpine nitrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pilocarpine nitrate belongs to the class of cholinergic agents, whereas many other glaucoma drugs such as beta‑blockers (e.g., timolol) or prostaglandin analogues (e.g., latanoprost) lower pressure via different mechanisms. Pilocarpine directly increases outflow, which can be advantageous in certain patients but may cause more ocular discomfort compared with some alternatives.

The product should be stored at room temperature, preferably below 25 °C, in its original container. Protect it from direct light and moisture to maintain stability. Do not freeze the solution, and keep the cap tightly closed when not in use.

Minims Pilocarpinenitraat is applied as an eye drop. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few seconds.

Serious adverse events include severe allergic reactions such as swelling or rash, sudden loss of visual acuity, and systemic cholinergic toxicity manifesting as nausea, bradycardia, or excessive sweating. Any of these symptoms require immediate medical evaluation.

Patients with known hypersensitivity to pilocarpine or other muscarinic agonists should avoid the product. It is also contraindicated in individuals with narrow‑angle glaucoma unless closely monitored, and caution is advised for those taking anticholinergic medications or systemic cholinesterase inhibitors.